Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026)

Inogen's (INGN) quarterly Non-Current Deffered Revenue came in at $3.2 million in Q1 2026, down 37.93% year-on-year from $5.1 million in Q1 2025, and down 12.02% on a QoQ basis from $3.6 million in Q4 2025.

Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Inogen (INGN) has 14 years of Non-Current Deffered Revenue data on file, last reported at $3.2 million in Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 37.93% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 37.93% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 37.31% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $3.2 million, down from $3.6 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for INGN reached as high as $11.5 million in Q1 2022 and fell as low as $3.2 million in Q1 2026.
  • Historically, Non-Current Deffered Revenue has averaged $7.5 million across 5 years, with a median of $7.6 million in 2024.
  • Across the five-year window, Non-Current Deffered Revenue dropped 2.81% in 2022 and plunged 37.93% in 2026, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $10.4 million in 2022, then declined by 20.89% to $8.2 million in 2023, then plunged by 30.14% to $5.7 million in 2024, then slumped by 37.31% to $3.6 million in 2025, then retreated by 12.02% to $3.2 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $3.2 million in Q1 2026, $3.6 million in Q4 2025, and $4.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 512.79 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Inogen 172.68 Mn 62.51 Mn 37.86 Mn 3.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.17 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 4.08 Mn
Jun 30, 2025 4.59 Mn
Mar 31, 2025 5.11 Mn
Dec 31, 2024 5.75 Mn
Sep 30, 2024 6.44 Mn
Jun 30, 2024 7.07 Mn
Mar 31, 2024 7.61 Mn
Dec 31, 2023 8.23 Mn
Sep 30, 2023 8.88 Mn
Jun 30, 2023 9.35 Mn
Mar 31, 2023 9.80 Mn
Dec 31, 2022 10.40 Mn
Sep 30, 2022 11.03 Mn
Jun 30, 2022 11.40 Mn
Mar 31, 2022 11.51 Mn
Dec 31, 2021 11.86 Mn
Sep 30, 2021 12.14 Mn
Jun 30, 2021 12.19 Mn